Skip to main content

OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative

Anurag Hans and Dr Jérôme Salomon_WHO SPECS_December_2024

From left to right: Anurag Hans, Head of Mission at EssilorLuxottica and President of the OneSight EssilorLuxottica Foundation, and Dr. Jérôme Salomon, Assistant Director-General, Universal Health Coverage, Communicable and Noncommunicable Diseases, WHO, formalize their collaboration under the WHO SPECS 2030 initiative. This collaboration marks a milestone effort to advance global vision care and expand access for underserved communities worldwide.
From left to right: Anurag Hans, Head of Mission at EssilorLuxottica and President of the OneSight EssilorLuxottica Foundation, and Dr. Jérôme Salomon, Assistant Director-General, Universal Health Coverage, Communicable and Noncommunicable Diseases, WHO, formalize their collaboration under the WHO SPECS 2030 initiative. This collaboration marks a milestone effort to advance global vision care and expand access for underserved communities worldwide.

OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative 

Paris, France and Geneva, Switzerland (6 December 2024) – The OneSight EssilorLuxottica Foundation is proud to announce its collaboration with the World Health Organization (WHO) as a global collaborating partner on the WHO’s SPECS 2030 initiative.

The SPECS initiative builds on the world’s first-ever global target to increase effective refractive error coverage by 40% by 2030, which was endorsed by WHO Member States in 2021 at the World Health Assembly. 

This collaboration between WHO and the Foundation represents a significant step forward in addressing refractive error, preventing myopia, and improving access to vision care worldwide, particularly in low-resource settings. 

The collaboration will focus on knowledge sharing, technical input, and data provision to scale impactful solutions and ensure the effective implementation of United Nations’ ‘Vision for Everyone’ resolution. By leveraging their respective expertise, WHO and the Foundation aim to make sustainable vision care accessible to millions, improving health outcomes and social inclusion. 

Dr Jérôme Salomon, Assistant Director-General, Universal Health Coverage, Communicable and Noncommunicable Diseases, WHO, emphasized the importance of collaborative action in achieving global eye health targets: “Vision care is not just a health priority – it is a social and economic imperative. The SPECS 2030 initiative, which underpins the UN ‘Vision for Everyone’ resolution, reminds us that effective collaboration can amplify impact, delivering tangible results for communities worldwide.” 

The WHO SPECS 2030 initiative accelerates global eye health efforts by focusing on five key pillars: Services, improving access to refractive services; Personnel, building the capacity of eye care professionals; Education, promoting public awareness about eye health; Cost, reducing the cost of eyeglasses and services; and Surveillance, strengthening data collection and research. 

Across these areas, the Foundation will provide technical input, share best practices, and contribute data to inform WHO’s initiatives in alignment with the global eye care target of effective refractive error coverage. 

Anurag Hans, Head of Mission at EssilorLuxottica and President of the OneSight EssilorLuxottica Foundation, highlighted the transformative potential of the collaboration: “Uncorrected poor vision affects 2.7 billion people worldwide, posing a significant global challenge. As a result of the Foundation’s efforts, 961 million people in some of the most remote communities now have access to vision care services within a day’s travel, and 84 million pairs of eyeglasses have been provided to those in need. However, achieving the Foundation’s ambition of eliminating uncorrected poor vision in a generation will require collaborations that amplify impact. By uniting WHO’s leadership in public health with our expertise in delivering innovative, on-the-ground solutions, we believe we can create a multiplier effect to extend vision care to even the most underserved regions. Together, we have the power to transform lives and uplift entire communities.

This collaboration reflects a shared commitment to improving lives through better vision and advancing progress toward Sustainable Development Goals, especially in health, education, and economic participation.

From left to right: Anurag Hans, Head of Mission at EssilorLuxottica and President of the OneSight EssilorLuxottica Foundation, and Dr. Jérôme Salomon, Assistant Director-General, Universal Health Coverage, Communicable and Noncommunicable Diseases, WHO, formalize their collaboration under the WHO SPECS 2030 initiative. This collaboration marks a milestone effort to advance global vision care and expand access for underserved communities worldwide.

CONTACTS:

OneSight EssilorLuxottica Foundation
Mission & Foundation Communications
Marco Catalani, Lauren Wyper
media@essilorluxottica.com

About the OneSight EssilorLuxottica Foundation
The OneSight EssilorLuxottica Foundation is a registered charitable organization reflecting the commitment of EssilorLuxottica to eliminate uncorrected poor vision in a generation. It brings together EssilorLuxottica’s philanthropic, advocacy actions and investments. With nine regional affiliate offices, the Foundation has created sustainable access to vision care to millions of people in underserved communities around the world.https://onesight.essilorluxottica.com/

About The World Health Organization 
Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. www.who.int

Attachments

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.